Fatty acids, cognition, behavior, brain development, and mood diseases

Fatty Acids in Foods and their Health Implications, Third Edition

Volumn , Issue , 2007, Pages 935-954

  Edouard Bourre, Jean Marie ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELL MEMBRANES; CYTOLOGY; PHOSPHOLIPIDS;

ALPHA LINOLENIC ACIDS; ARACHIDONIC ACIDS; BRAIN DEVELOPMENT; DOCOSAPENTAENOIC ACID; MEMBRANE PHOSPHOLIPIDS; OMEGA-3-FATTY ACIDS; OMEGA-6 FATTY ACIDS; SOURCES OF ENERGY;

POLYUNSATURATED FATTY ACIDS;

EID: 78650989894     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (151)

1. Agostoni, C., Marangoni, F., Giovannini, M., Galli, C., and Riva, E. (2001). Prolonged breast-feeding (six months or more) and milk fat content at six months are associated with higher developmental scores at one year of age within a breast-fed population. Adv. Exp. Med. Biol. 501: 137-141.
2. Agostoni, C., Riva, E., Bellu, R., Trojan, S., Luotti, D., and Giovannini, M. (1994). Effects of diet on the lipid and fatty acid status of full-term infants at 4 months. J. Am. Coll. Nutr. 13: 658-664.
3. Agostoni, C., Trojan, S., Bellu, R., Riva, E., Bruzzese, M. G., and Giovannini, M. (1997). Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch. Dis. Child. 76: 421-424.
4. Agostoni, C., Trojan, S., Bellu, R., Riva, E., and Giovannini, M. (1995). Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr. Res. 38: 262-266.
5. Aid, S., Vancassel, S., Poumes-Ballihaut, C., Chalon, S., Guesnet, P., and Lavialle, M. (2003). Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J. Lipid Res. 44: 1545-1551.
6. Angelsen, N. K., Vik, T., Jacobsen, G., and Bakketeig, L. S. (2001). Breast feeding and cognitive development at age 1 and 5 years. Arch. Dis. Child. 85: 183-188.
7. Arvindakshan, M., Ghate, M., Ranjekar, P. K., Evans, D. R., and Mahadik, S. P. (2003). Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr. Res. 62: 195-204.
8. Assies, J., Lieverse, R., Vreken, P., Wanders, R. J., Dingemans, P. M., and Linszen, D. H. (2001). Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry 49: 510-522.
9. Auestad, N., Scott, D. T., Janowsky, J. S., et al. (2003). Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112: e177-e183.
10. Bakker, E. C., Ghys, A. J., Kester, A. D., Vles, J. S., Dubas, J. S., Blanco, C. E., and Hornstra, G. (2003). Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur. J. Clin. Nutr. 57: 89-95.
11. Barberger-Gateau, P., Jutand, M. A., Letenneur, L., Larrieu, S., Tavernier, B., and Berr, C. (2005). Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur. J. Clin. Nutr. 59: 817-825.
12. Barberger-Gateau, P., Letenneur, L., Deschamps, V., Peres, K., Dartigues, J. F., and Renaud, S. (2002). Fish, meat, and risk of dementia: cohort study. BMJ 325: 932-933.
13. Bates, C. E. (1988). Racially determined abnormal essential fatty acid and prostaglandin metabolism and food allergies linked to autoimmune, inflammatory, and psychiatric disorders among Coastal British Columbia Indians. Med. Hypotheses 25: 103-109.
14. Bazan, N. G. and Scott, B. L. (1990). Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses. Ups. J. Med. Sci. Suppl. 48: 97-107.
15. Bell, J. G., Sargent, J. R., Tocher, D. R., and Dick, J. R. (2000). Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot. Essent. Fatty Acids 63: 21-25.
16. Birch, E. E., Hoffman, D. R., Castaneda, Y. S., Fawcett, S. L., Birch, D. G., and Uauy, R. D. (2002). A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am. J. Clin. Nutr. 75: 570-580.
17. Bourre, J. M. (1990). La diététique du cerveau. Editions Odile Jacob, Paris, France. (1991) De la inteligencia y el placer, la dietetica del cerebro, Biblioteca Mondatori. (1992) Intelligenz und Ernährung, Econ Verlag, Germany. (1992) La dietetica del cervello, Sperling Kupfer, Italy. (1993) Comida inteligente, a diétetica do cérebro, Gradiva. (1993) Brainfood, Little Brown, U.S.A.
18. Bourre, J. M. (2003). Diététique du cerveau: la nouvelle donne. Paris: Edition Odile Jacob.
19. Bourre, J. M. (2004a). The role of nutritional factors on the structure and function of the brain: an update on dietary requirements. Rev. Neurol. (Paris) 160: 767-792.
20. Bourre, J. M. (2004b). Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8: 163-174.
21. Bourre, J. M. (2004c). La vérité sur les oméga-3. Paris: Edition Odile Jacob.
22. Bourre, J. M. (2005a). Dietary omega-3 Fatty acids and psychiatry: mood, behavior, stress, depression, dementia and aging. J. Nutr. Health Aging 9: 31-38.
23. Bourre, J. M. (2005b). Where to find omega-3 fatty acids and how feeding animals with diet enriched in omega-3 fatty acids to increase nutritional value of derived products for human: what is actually useful? J. Nutr. Health Aging 9: 232-242.
24. Bourre, J. M., Bonneil, M., Dumont, O., Piciotti, M., Calaf, R., Portugal, H., Nalbone, G., and Lafont, H. (1990). Effect of increasing amounts of dietary fish oil on brain and liver fatty composition. Biochim. Biophys. Acta 1043: 149-152.
25. Bourre, J. M., Daudu, O., and Baumann, N. (1976). Ontogenesis of three fatty acid synthesizing systems in cerebral microsomes: relation to myelinization. Biochimie 58: 1277-1279.
26. Bourre, J. M. and Dumont, O. (2003). Dietary oleic acid not used during brain development and in adult in rat, in contrast with sciatic nerve. Neurosci. Lett. 336: 180-184.
27. Bourre, J. M., Dumont, O. L., Clement, M. E., and Durand, G. A. (1997). Endogenous synthesis cannot compensate for absence of dietary oleic acid in rats. J. Nutr. 127: 488-493.
28. Bourre, J. M., Durand, G., Pascal, G., and Youyou, A. (1989a). Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J. Nutr. 119: 15-22.
29. Bourre, J. M., Francois, M., Youyou, A., Dumont, O., Piciotti, M., Pascal, G., and Durand, G. (1989b). The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119: 1880-1892.
30. Bourre, J. M., Faivre, A., Dumont, O., Nouvelot, A., Loudes, C., Puymirat, J., and Tixier-Vidal, A. (1983). Effect of polyunsaturated fatty acids on fetal mouse brain cells in culture in a chemically defined medium. J. Neurochem. 41: 1234-1242.
31. Bourre, J. M., Pascal, G., Durand, G., Masson, M., Dumont, O., and Piciotti, M. (1984). Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem. 43: 342-348.
32. Bourre, J. M., Paturneau-Jouas, M. Y., Daudu, O. L., and Baumann, N. A. (1977). Lignoceric acid biosynthesis in the developing brain. Activities of mitochondrial acetyl-CoA-dependent synthesis and microsomal malonyl-CoA chain-elongating system in relation to myelination. Comparison between normal mouse and dysmyelinating mutants (quaking and jimpy). Eur. J. Biochem. 72: 41-47.
33. Bouwstra, H., Boersma, E. R., Boehm, G., Dijck-Brouwer, D. A., Muskiet, F. A., and Hadders-Algra, M. (2003). Exclusive breastfeeding of healthy term infants for at least 6 weeks improves neurological condition. J. Nutr. 133: 4243-4245.
34. Bowen, R. A. and Clandinin, M. T. (2000). High dietary 18:3n-3 increases the 18:3n-3 but not the 22:6n-3 content in the whole body, brain, skin, epididymal fat pads, and muscles of suckling rat pups. Lipids 35: 389-394.
35. Broadhurst, C. L., Wang, Y., Crawford, M. A., Cunnane, S. C., Parkington, J. E., and Schmidt, W. F. (2002). Brain-specific lipids from marine, lacustrine, or terrestrial food resources: potential impact on early African Homo sapiens. Comp Biochem. Physiol B Biochem. Mol. Biol. 131: 653-673.
36. Buydens-Branchey, L., Branchey, M., McMakin, D. L., and Hibbeln, J. R. (2003a). Polyunsaturated fatty acid status and relapse vulnerability in cocaine addicts. Psychiatry Res. 120: 29-35.
37. Buydens-Branchey, L., Branchey, M., McMakin, D. L., and Hibbeln, J. R. (2003b). Polyunsaturated fatty acid status and aggression in cocaine addicts. Drug Alcohol Depend. 71: 319-323.
38. Byard, R. W., Makrides, M., Need, M., Neumann, M. A., and Gibson, R. A. (1995). Sudden infant death syndrome: effect of breast and formula feeding on frontal cortex and brainstem lipid composition. J. Paediatr. Child Health 31: 14-16.
39. Carlson, S. E. (2000). Behavioral methods used in the study of long-chain polyunsaturated fatty acid nutrition in primate infants. Am. J. Clin. Nutr. 71: 268S-274S.
40. Carrie, I., Guesnet, P., Bourre, J. M., and Frances, H. (2000). Diets containing long-chain n-3 polyunsaturated fatty acids affect behavior differently during development than ageing in mice. Br. J. Nutr. 83: 439-447.
41. Chalon, S., Vancassel, S., Zimmer, L., Guilloteau, D., and Durand, G. (2001). Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 36: 937-944.
42. Cheon, S. H., Huh, M. H., Lee, Y. B., Park, J. S., Sohn, H. S., and Chung, C. W. (2000). Effect of dietary linoleate/alpha-linolenate balance on the brain lipid composition, reproductive outcome and behavior of rats during their prenatal and postnatal development. Biosci. Biotechnol. Biochem. 64: 2290-2297.
43. Chiu, C. C., Huang, S. Y., Shen, W. W., and Su, K. P. (2003). Omega-3 fatty acids for depression in pregnancy. Am. J. Psychiatry 160: 385.
44. Clandinin, M. T., Chappell, J. E., Leong, S., Heim, T., Swyer, P. R., and Chance, G. W. (1980a). Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum. Dev. 4: 131-138.
45. Clandinin, M. T., Chappell, J. E., Leong, S., Heim, T., Swyer, P. R., and Chance, G. W. (1980b). Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements. Early Hum. Dev. 4: 121-129.
46. Clement, M., Dinh, L., and Bourre, J. M. (1995). Uptake of dietary RRR-a. Biochim. Biophys. Acta 1256: 175-180.
47. Cohen, J. T., Bellinger, D. C., Connor, W. E., and Shaywitz, B. A. (2005). A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am. J. Prev. Med. 29: 366-374.
48. Colin, A., Reggers, J., Castronovo, V., and Ansseau, M. (2003). [Lipids, depression and suicide]. Encephale 29: 49-58.
49. Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., and Fisher, R. H. (2000). Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids 35: 1305-1312.
50. Coscina, D. V., Yehuda, S., Dixon, L. M., Kish, S. J., and Leprohon-Greenwood, C. E. (1986). Learning is improved by a soybean oil diet in rats. Life Sci. 38: 1789-1794.
51. Crawford, M. A., Bloom, M., Cunnane, S., et al. (2001). Docosahexaenoic acid and cerebral evolution. World Rev. Nutr. Diet. 88: 6-17.
52. Cunnane, S. C., Francescutti, V., Brenna, J. T., and Crawford, M. A. (2000). Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 35: 105-111.
53. Cunnane, S. C., Nadeau, C. R., and Likhodii, S. S. (2001). NMR and isotope ratio mass spectrometry studies of in vivo uptake and metabolism of polyunsaturates by the developing rat brain. J. Mol. Neurosci. 16: 173-180.
54. de la Presa, O. S. and Innis, S. M. (1999). Docosahexaenoic and arachidonic acid Prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J. Nutr. 129: 2088-2093.
55. de Wilde, M. C., Farkas, E., Gerrits, M., Kiliaan, A. J., and Luiten, P. G. (2002). The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res. 947: 166-173.
56. du Bois, T. M., Deng, C., Bell, W., and Huang, X. F. (2006). Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 139: 1397-1403.
57. du Bois, T. M., Deng, C., and Huang, X. F. (2005). Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29: 878-888.
58. Emsley, R., Myburgh, C., Oosthuizen, P., and van Rensburg, S. J. (2002). Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am. J. Psychiatry 159: 1596-1598.
59. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., et al. (2002). Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 59: 1915-1921.
60. Fenton, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R., and Knable, M. (2001). A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am. J. Psychiatry 158: 2071-2074.
61. Fleith, M. and Clandinin, M. T. (2005). Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev. Food Sci. Nutr. 45: 205-229.
62. Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., and Lodi, L. (2005). Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J. Clin. Invest. 35: 691-699.
63. Frances, H., Coudereau, J. P., Sandouk, P., Clement, M., Monier, C., and Bourre, J. M. (1996a). Influence of a dietary alpha-linolenic acid deficiency on learning in the Morris water maze and on the effects of morphine. Eur. J. Pharmacol. 298: 217-225.
64. Frances, H., Monier, C., Clement, M., Lecorsier, A., Debray, M., and Bourre, J. M. (1996b). Effect of dietary alpha-linolenic acid deficiency on habituation. Life Sci. 58: 1805-1816.
65. Frances, H., Drai, P., Smirnova, M., Carrie, I., Debray, M., and Bourre, J. M. (2000). Nutritional (n-3) polyunsaturated fatty acids influence the behavioral responses to positive events in mice. Neurosci. Lett. 285: 223-227.
66. Frances, H., Monier, C., and Bourre, J. M. (1995). Effects of dietary alpha-linolenic acid deficiency on neuromuscular and cognitive functions in mice. Life Sci. 57: 1935-1947.
67. Frasure-Smith, N., Lesperance, F., and Julien, P. (2004). Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 55: 891-896.
68. Galli, C., Trzeciak, H. I., and Paoletti, R. (1972). Effects of essential fatty acid deficiency on myelin and various subcellular structures in rat brain. J. Neurochem. 19: 1863-1867.
69. Gibson, R. A., Neumann, M. A., and Makrides, M. (1996). Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants. Lipids 31(Suppl): S177-S181.
70. Gustafsson, P. A., Duchen, K., Birberg, U., and Karlsson, T. (2004). Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6 1/2 years of age. Acta Paediatr. 93: 1280-1287.
71. Hakkarainen, R., Partonen, T., Haukka, J., Virtamo, J., Albanes, D., and Lonnqvist, J. (2004a). Food and nutrient intake in relation to mental wellbeing. Nutr. J. 3: 14.
72. Hakkarainen, R., Partonen, T., Haukka, J., Virtamo, J., Albanes, D., and Lonnqvist, J. (2004b). Is low dietary intake of omega-3 fatty acids associated with depression? Am. J. Psychiatry 161: 567-569.
73. Hamazaki, T., Thienprasert, A., Kheovichai, K., Samuhaseneetoo, S., Nagasawa, T., and Watanabe, S. (2002). The effect of docosahexaenoic acid on aggression in elderly Thai subjects—a placebo-controlled double-blind study. Nutr. Neurosci. 5: 37-41.
74. Heird, W. C. and Lapillonne, A. (2005). The role of essential fatty acids in development. Annu. Rev. Nutr. 25: 549-571.
75. Helland, I. B., Smith, L., Saarem, K., Saugstad, O. D., and Drevon, C. A. (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 111: e39-e44.
76. Heude, B., Ducimetiere, P., and Berr, C. (2003). Cognitive decline and fatty acid composition of erythrocyte membranes—the EVA study. Am. J. Clin. Nutr. 77: 803-808.
77. Hibbeln, J. R. (2002). Seafood consumption, the DHA content of mothers’ milk and Prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69: 15-29.
78. Hibbeln, J. R., Makino, K. K., Martin, C. E., Dickerson, F., Boronow, J., and Fenton, W. S. (2003). Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol. Psychiatry 53: 431-441.
79. Hibbeln, J. R., Nieminen, L. R., and Lands, W. E. (2004). Increasing homicide rates and linoleic acid consumption among five Western countries, 1961-2000. Lipids 39: 1207-1213.
80. Hibbeln, J. R. and Salem, N., Jr. (1995). Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am. J. Clin. Nutr. 62: 1-9.
81. Horrobin, D. F. (2003). Omega-3 Fatty acid for schizophrenia. Am. J. Psychiatry 160: 188-189.
82. Horwood, L. J., Darlow, B. A., and Mogridge, N. (2001). Breast milk feeding and cognitive ability at 7-8 years. Arch. Dis. Child. Fetal Neonatal Ed. 84: F23-F27.
83. Hung, M. C., Shibasaki, K., Yoshida, R., Sato, M., and Imaizumi, K. (2001). Learning behavior and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: influence of a phosphatidylcholine-vitamin B12 diet. Br. J. Nutr. 86: 163-171.
84. Johnson, S. M. and Hollander, E. (2003). Evidence that eicosapentaenoic acid is effective in treating autism. J. Clin. Psychiatry 64: 848-849.
85. Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A., and Breteler, M. M. (1997a). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42: 776-782.
86. Kalmijn, S., Feskens, E. J., Launer, L. J., and Kromhout, D. (1997b). Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145: 33-41.
87. Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., and Launer, L. J. (2000). Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler. Thromb. Vasc. Biol. 20: 2255-2260.
88. Kalmijn, S., van Boxtel, M. P., Ocke, M., Verschuren, W. M., Kromhout, D., and Launer, L. J. (2004). Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62: 275-280.
89. Kodas, E., Galineau, L., Bodard, S., Vancassel, S., Guilloteau, D., Besnard, J. C., and Chalon, S. (2004). Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J. Neurochem. 89: 695-702.
90. Kodas, E., Vancassel, S., Lejeune, B., Guilloteau, D., and Chalon, S. (2002). Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J. Lipid Res. 43: 1209-1219.
91. Lanting, C. I., Fidler, V., Huisman, M., Touwen, B. C., and Boersma, E. R. (1994). Neurological differences between 9-year-old children fed breast-milk or formula-milk as babies. Lancet 344: 1319-1322.
92. Laugharne, J. D., Mellor, J. E., and Peet, M. (1996). Fatty acids and schizophrenia. Lipids 31(Suppl): S163-S165.
93. Levant, B., Radel, J. D., and Carlson, S. E. (2004). Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 152: 49-57.
94. Lim, S. and Suzuki, H. (2001). Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J. Nutr. 131: 319-324.
95. Llorente, A. M., Jensen, C. L., Voigt, R. G., Fraley, J. K., Berretta, M. C., and Heird, W. C. (2003). Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstet. Gynecol. 188: 1348-1353.
96. Lombard, C. B. (2000). What is the role of food in Preventing depression and improving mood, performance and cognitive function? Med. J. Aust. 173(Suppl): S104-S105.
97. Lucas, A., Morley, R., Cole, T. J., Lister, G., and Leeson-Payne, C. (1992). Breast milk and subsequent intelligence quotient in children born preterm. Lancet 339: 261-264.
98. Mamalakis, G., Tornaritis, M., and Kafatos, A. (2002). Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 67: 311-318.
99. Marangell, L. B., Martinez, J. M., Zboyan, H. A., Chong, H., and Puryear, L. J. (2004). Omega-3 fatty acids for the Prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress. Anxiety 19: 20-23.
100. Marangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F., and Puryear, L. J. (2003). A doubleblind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 160: 996-998.
101. McCann, J. C. and Ames, B. N. (2005). Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 82: 281-295.
102. Mischoulon, D. and Fava, M. (2000). Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatr. Clin. North Am. 23: 785-794.
103. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., and Schneider, J. (2003a). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60: 940-946.
104. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., Schneider, J., and Wilson, R. S. (2003b). Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60: 194-200.
105. Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., and Wilson, R. S. (2005). Fish consumption and cognitive decline with age in a large community study. Arch. Neurol. 62: 1849-1853.
106. Murck, H., Song, C., Horrobin, D. F., and Uhr, M. (2004). Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. Int. J. Neuropsychopharmacol. 7: 341-349.
107. Nemets, B., Stahl, Z., and Belmaker, R. H. (2002). Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry 159: 477-479.
108. Ness, A. R., Gallacher, J. E., Bennett, P. D., Gunnell, D. J., Rogers, P. J., Kessler, D., and Burr, M. L. (2003). Advice to eat fish and mood: a randomised controlled trial in men with angina. Nutr. Neurosci. 6: 63-65.
109. Noaghiul, S. and Hibbeln, J. R. (2003). Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am. J. Psychiatry 160: 2222-2227.
110. Otsuka, M. (2000). [Analysis of dietary factors in Alzheimer’s disease: clinical use of nutritional intervention for Prevention and treatment of dementia]. Nippon Ronen Igakkai Zasshi 37: 970-973.
111. Otsuka, M., Yamaguchi, K., and Ueki, A. (2002). Similarities and differences between Alzheimer’s disease and vascular dementia from the viewpoint of nutrition. Ann. N. Y. Acad. Sci. 977: 155-161.
112. Paine, B. J., Makrides, M., and Gibson, R. A. (1999). Duration of breast-feeding and Bayley’s Mental Developmental Index at 1 year of age. J. Paediatr. Child Health 35: 82-85.
113. Peet, M. (2003). Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot. Essent. Fatty Acids 69: 477-485.
114. Peet, M., Brind, J., Ramchand, C. N., Shah, S., and Vankar, G. K. (2001). Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr. Res. 49: 243-251.
115. Peet, M. and Horrobin, D. F. (2002). A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch. Gen. Psychiatry 59: 913-919.
116. Peet, M., Laugharne, J. D., Mellor, J., and Ramchand, C. N.(1996). Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot. Essent. Fatty Acids 55: 71-75.
117. Puri, B. K., Counsell, S. J., Hamilton, G., Richardson, A. J., and Horrobin, D. F. (2001). Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int. J. Clin. Pract. 55: 560-563.
118. Puri, B. K., Richardson, A. J., Horrobin, D. F., Easton, T., Saeed, N., Oatridge, A., Hajnal, J. V., and Bydder, G. M. (2000). Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int. J. Clin. Pract. 54: 57-63.
119. Richardson, A. J., Calvin, C. M., Clisby, C., Schoenheimer, D. R., Montgomery, P., Hall, J. A., Hebb, G., Westwood, E., Talcott, J. B., and Stein, J. F. (2000). Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot. Essent. Fatty Acids 63: 69-74.
120. Richardson, A. J. and Puri, B. K. (2000). The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 63: 79-87.
121. Richardson, A. J. and Ross, M. A. (2000). Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 63: 1-9.
122. Rodriguez, A., Raederstorff, D., Sarda, P., Lauret, C., Mendy, F., and Descomps, B. (2003). Preterm infant formula supplementation with alpha linolenic acid and docosahexaenoic acid. Eur. J. Clin. Nutr. 57: 727-734.
123. Salem, N., Jr., Moriguchi, T., Greiner, R. S., et al. (2001). Alterations in brain function after loss of docosa- hexaenoate due to dietary restriction of n-3 fatty acids. J. Mol. Neurosci. 16: 299-307.
124. Silvers, K. M. and Scott, K. M. (2002). Fish consumption and self-reported physical and mental health status. Public Health Nutr. 5: 427-431.
125. Simmer, K. (2001). Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane. Database. Syst. Rev. 4: CD000376.
126. Simmer, K. and Patole, S. (2004). Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane. Database. Syst. Rev. 1: CD000375.
127. Simopoulos, A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21: 495-505.
128. Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Capurso, S., Gadaleta, A., Capurso, A., and Panza, F. (2005). Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp. Gerontol. 40: 257-270.
129. Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S. S., Arnold, L. E., and Burgess, J. R. (2003). EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 38: 1007-1021.
130. Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., and Marangell, L. B. (1999). Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo- controlled trial. Arch. Gen. Psychiatry 56: 407-412.
131. Su, K. P., Huang, S. Y., Chiu, C. C., and Shen, W. W. (2003). Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 13: 267-271.
132. Sublette, E. and Trappler, B. (2000). Cultural sensitivity training in mental health: treatment of Orthodox Jewish psychiatric inpatients. Int. J. Soc. Psychiatry 46: 122-134.
133. Tanskanen, A., Hibbeln, J. R., Tuomilehto, J., Uutela, A., Haukkala, A., Viinamaki, H., Lehtonen, J., and Vartiainen, E. (2001). Fish consumption and depressive symptoms in the general population in Finland. Psychiatr. Serv. 52: 529-531.
134. Taylor, K. E., Higgins, C. J., Calvin, C. M., Hall, J. A., Easton, T., McDaid, A. M., and Richardson, A. J. (2000). Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukot. Essent. Fatty Acids 63: 75-78.
135. Tiemeier, H., van Tuijl, H. R., Hofman, A., Kiliaan, A. J., and Breteler, M. M. (2003). Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 78: 40-46.
136. Uauy, R., Hoffman, D. R., Mena, P., Llanos, A., and Birch, E. E. (2003). Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J. Pediatr. 143: S17-S25.
137. Udell, T., Gibson, R. A., and Makrides, M. (2005). The effect of alpha-linolenic acid and linoleic acid on the growth and development of formula-fed infants: a systematic review and meta-analysis of randomized controlled trials. Lipids 40: 1-11.
138. Vancassel, S., Durand, G., Barthelemy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andres, C., and Chalon, S. (2001). Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 65: 1-7.
139. Voigt, R. G., Jensen, C. L., Fraley, J. K., Rozelle, J. C., Brown, F. R., III, and Heird, W. C. (2002). Relationship between omega 3 long-chain polyunsaturated fatty acid status during early infancy and neurodevelopmental status at 1 year of age. J. Hum. Nutr. Diet. 15: 111-120.
140. Voigt, R. G., Llorente, A. M., Jensen, C. L., Fraley, J. K., Berretta, M. C., and Heird, W. C. (2001). A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 139: 189-196.
141. Wainwright, P. E. (2002). Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc. Nutr. Soc. 61: 61-69.
142. Wainwright, P. E., Huang, Y. S., Coscina, D. V., Levesque, S., and McCutcheon, D. (1994). Brain and behavioral effects of dietary n-3 deficiency in mice: a three generational study. Dev. Psychobiol. 27: 467-487.
143. Wezel-Meijler, G., van der Knaap, M. S., Huisman, J., Jonkman, E. J., Valk, J., and Lafeber, H. N. (2002). Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation. Acta Paediatr. 91: 942-950.
144. Whalley, L. J., Fox, H. C., Wahle, K. W., Starr, J. M., and Deary, I. J. (2004). Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am. J. Clin. Nutr. 80: 1650-1657.
145. Willatts, P. (2002). Long chain polyunsaturated fatty acids improve cognitive development. J. Fam. Health Care 12: 5.
146. Willatts, P., Forsyth, J. S., DiModugno, M. K., Varma, S., and Colvin, M. (1998). Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352: 688-691.
147. Yamamoto, N., Hashimoto, A., Takemoto, Y., et al. (1988). Effect of the dietary alpha-linolenate/linoleate balance on lipid compositions and learning ability of rats. II. Discrimination process, extinction process, and glycolipid compositions. J. Lipid Res. 29: 1013-1021.
148. Yehuda, S., Rabinovtz, S., Carasso, R. L., and Mostofsky, D. I. (1996). Essential fatty acids preparation (SR-3) improves Alzheimer’s patients quality of life. Int. J. Neurosci. 87: 141-149.
149. Yehuda, S., Rabinovitz, S., Carasso, R. L., and Mostofsky, D. I. (2000). Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning. Int. J. Neurosci. 101: 73-87.
150. Yoshida, S., Miyazaki, M., Takeshita, M., Yuasa, S., Kobayashi, T., Watanabe, S., and Okuyama, H. (1997). Functional changes of rat brain microsomal membrane surface after learning task depending on dietary fatty acids. J. Neurochem. 68: 1269-1277.
151. Zerouga, M., Beauge, F., Niel, E., Durand, G., and Bourre, J. M. (1991). Interactive effects of dietary (n-3) polyunsaturated fatty acids and chronic ethanol intoxication on synaptic membrane lipid composition and fluidity in rats. Biochim. Biophys. Acta 1086: 295-304.